Respiratory Care Devices Market Report Forecast by Device Type (Therapeutic, Monitoring, Diagnostic, Consumables, and accessories), Product Type (Respiratory Consumables, Nebulizers, Oxygen Concentrators, Polysomnography Devices, Pulse oximeters, Mechanical Ventilators, Spirometers, and Others), Application (Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, Asthma, Respiratory Distress Syndrome, Cystic Fibrosis, and Others), Country and Company Analysis 2024-2030

Respiratory Care Devices Market Analysis

Respiratory care device market size is expected to reach US$ 38.76 billion by 2030 up to US$ 22.32 billion in 2023, with a growth rate of 8.20% from 2024 to 2030.

By enhancing respiratory characteristics and providing support, respiratory care devices help patients with breathing disorders. With an older population that is more likely to get respiratory diseases, new technologies, and higher healthcare costs are all driving growth in this market. Respiratory conditions including pneumonia, sleep apnea, and COPD are more common among the aged. Records from the WHO indicate that more than 2 billion individuals would be 60 years of age or older by 2050.

By identifying, tracking, and treating respiratory conditions including COPD, asthma, TB, and pneumonia, respiratory care devices enhance the quality of respiratory illnesses. The market for respiratory care equipment is driven by the rising incidence of respiratory illnesses, population growth, and the need for home care environments. The need for effective breathing care solutions is rising due to environmental conditions and aging populations. Technology and AI developments have completely changed the healthcare sector. With the release of Airofit Pro, a customized respiratory training system intended to strengthen respiratory muscles, breathing devices have seen a substantial improvement. At USD 422.74, this unique gadget is anticipated to drive market expansion.

Global Respiratory Care Devices Market Size, 2024-2030 (Billion US$)

Note: The chart above shows dummy data and is only for illustration purposes. Please get in touch with us for the actual market size and trends.

Respiratory Care Devices Market Survey

• Chronic lung diseases, which incorporates hypersensitive reactions and COPD, have an effect on over 34 million human beings inside the United States.
• Over 6 million Canadians afflicted by intense respiratory diseases, with 3.8 million diagnosed and millions expected to be undiagnosed, in keeping with the Canadian Lung Association.
• In the UK, respiratory disease influences 1 in 5 people and is the 1/3 leading reason of death. By 2024, the number of patients with respiratory illnesses can be 104,439.
• Respiratory disease is a main cause of death in UK, affecting many peoples. Lung cancers, pneumonia, and COPD are the number one culprit.
• In 2023, respiration diseases affected 7.3 million people in France, inflicting 393,100 deaths and ensuing in a lack of 1.4 million life yearly.
• In Italy, breathing sicknesses purpose 82.1 thousand deaths and 1.5 million death yearly, affecting 6.1 million human beings as per International Respiratory Coalition.
• By November 2023, the number of human beings affected with continual obstructive pulmonary sickness in China had reached almost one hundred million, accounting for approximately 1/4th of all worldwide times of COPD.
• India allergic reactions burden come to be 34.3 million, accounting for 13.09% of the global burden. This respiratory illness for 27.9% of the disability-adjusted existence years in Indians, with three instances better mortality and instances better DALYs in comparison to international averages.
• In October 2022, 30 international locations with high T.B. Burden accounted for 87% of the modern T.B. Cases. The WHO South-East Asian Region had 46% new times, discovered by using the WHO African Region with 23% new times and the WHO Western Pacific with 18%.

United States Respiratory care devices market

The high incidence of respiratory diseases in the US, including COPD, TB, allergies, and sleep apnea, gives the country a substantial portion of the global market. The CDC predicts that 4.6% of American adults (those aged 18 and above) will have chronic obstructive pulmonary disease (COPD), emphysema, or chronic obstructive airway disease (COPD), which will fuel the market's expansion. In addition, cutting-edge R&D is fueling market growth through the introduction of groundbreaking products. Research and development (R&D) for respiratory diseases received $150 million in 2022 from the United States, $328 million from asthma, $621 million from TB, and $515 million from sleep apnea.

Respiratory Care Devices Company Analysis

The competitive landscape includes Medtronic P.C., Koninclick-Phillips, General Electric Company, Masimo Corporation, ResMed Inc., Becton Dickinson, Chart Industries Inc., Gettinge AB, and Inogen Inc.

Respiratory Care Devices Company News

Medtronic

• In February 2024, Medtronic introduced it planned to merge patient tracking and respiratory businesses and go out the ventilator marketplace.
• In October 2022, Medtronic deliberate to cut up its patient monitoring and respiratory intervention agencies from its medical-surgical portfolio. In 2021, they released a pediatric screen that notifies doctors of airway obstructions during ventilation.
• Medtronic released the Puritan Bennett 980 ventilator in 2020. It makes use of superior algorithms to provide personalized ventilation for patients with respiratory failure and offers a number of superior functions for respiration support.

Koninclick-Phillips

• In January 2024, Philips halted sales of breathing care products and sleep therapy devices in the US as a part of a consent decree with the USA Department of Justice.
• In 2021, Philips Healthcare released the Trilogy Evo ventilator, a sophisticated device designed for acute and chronic breathing failure patients. The device gives advanced ventilation modes, superior monitoring skills, and remote connectivity.

General Electric Company

• In 2020, G.E. Healthcare released the Carescape R860 ventilator, a sophisticated device with numerous air flow modes and advanced tracking abilities. It is designed to offer personalized ventilation for significantly sick patients with respiration failure.

Masimo Corporation

• Masimo Corporation bought NantHealth's Connected Care Business in January 2020. Through connectivity, automation, and step forward noninvasive tracking technology, Masimo could be capable of aid hospitals in providing steady care.

ResMed Inc.

• In 2021, ResMed launched its AirSense 11 AutoSet and AirSense 11 AutoSet for Her, two advanced non-stop fantastic airway stress (CPAP) devices that use synthetic intelligence to adjust pressure stages routinely to optimize patient consolation and remedy.
• In 2020, ResMed released the AirFit F30i complete-face masks, a revolutionary tool designed to provide maximum comfort and freedom of movement for patients with sleep apnea. The tool features a unique cushion layout and a number of advanced features for premiere patients consolation.

Getting AB

• In January 2023, Getinge launched the Servo-C, a brand new mechanical ventilator for in depth care devices (ICUs) which could treat adults and youngsters.

Inogen Inc.

• Rove 6 become released in Europe in December 2022, and this 6-setting device has an anticipated carrier existence of 8 years.
• Rove four, a 4-placing device launched inside the U.S. In 2023, received FDA marketplace clearance in December 2022.
• Inogen acquired New Aera, a producer of portable, noninvasive ventilators, for $70.4 million in cash in 2019.

Global Respiratory Care Devices Market Share, By Application (Percentage)

Note: The chart above shows dummy data and is only for illustration purposes. Please get in touch with us for the actual market size and trends.

Device Type – Market has been covered from 4 viewpoints

1.    Therapeutic Devices
2.    Monitoring Devices
3.    Diagnostic Devices
4.    Consumables & Accessories

Products – Market has been covered from 8 viewpoints

1.    Respiratory Consumables
2.    Nebulizers
3.    Oxygen Concentrators
4.    Polysomnography Devices
5.    Pulse Oximeter
6.    Mechanical Ventilators
7.    Spirometers
8.    Others

Application – Market has been covered from 6 viewpoints

1.    Chronic Obstructive Pulmonary Disease (COPD)
2.    Obstructive Sleep Apnea
3.    Asthma
4.    Respiratory Distress Syndrome
5.    Cystic Fibrosis
6.    Others

End Users – Market has been covered from 3 viewpoints

1.    Hospitals
2.    Home Care
3.    Ambulatory Care

Country – This report covers the 18 countries

1.    North America

1.1    United States
1.2    Canada

2.    Latin America

2.1    Mexico
2.2    Brazil

3.    Europe

3.1    United Kingdom
3.2    Germany
3.3    France
3.4    Italy
3.5    Spain
3.6    Netherlands

4.    Asia Pacific

4.1    China
4.2    Japan
4.3    India
4.4    South Korea
4.5    Australia

5.    Middle East & Africa

5.1    United Arab Emirates
5.2    South Africa

6.    Rest of the World

All the companies have been studied from 3 points

•    Business Overview
•    Recent Developments
•    Sales Analysis

Company Analysis

1.    Medtronic Plc
2.    Koninklijke Philips
3.    General Electric Company
4.    Masimo Corporation
5.    ResMed Inc.
6.    Becton Dickinson
7.    Chart Industries Inc.
8.    Getinge AB
9.    InogenInc

Report Details: